Receptor-interacting protein 140 (RIP140) is overexpressed in TAMs, which inhibits the alternative activation of Mφ and has an inhibitory effect on the progression of HCC by suppressing the NF-κB/IL-6 axis (Hu et al., 2017). The gene discussed is IL6; the disease is hepatocellular carcinoma.